RGEN
Repligen Corporation

Repligen CorporationRGEN

144.24USD
+0.21%
Sep 23, 2026
RGEN overview ready
The chart confirms it.
This is what Trading Compass has established for Repligen Corporation so far; the remaining research is not yet available.
Narrative not measured
An early price trend
Longer-term context reads early recovery, with a near-term setup of daily reclaim.
Valuation not measured
Fundamentals not measured
Market Jul 13Filing Jun 30Price action Jul 13

Conviction Level

Theme Heat, Company Position have no canonical measurement for this company — research-profile dimensions, not inputs to this score.

NarrativeHeat—ThemeHeat—PriceAction7.5Valuation—CompanyPosition—
Price
Loading price history…

Price Action

An early price trend
Longer-term context reads early recovery, with a near-term setup of daily reclaim.

Key Financials

Market Cap
$8.1B
Avg Volume (60D)
1.2M
60 sessions
Revenue Growth YoY
+16.4%
FY2025 vs FY2024
Operating Margin
+8.2%
Trailing twelve months
Free Cash Flow Yield
+1.4%
P/E
196.0x
EV / EBITDA
55.0x
EV / Sales
10.0x
Market metrics as of Jul 13, 2026
Financial results for the period ended Jun 30, 2026
Filed balance-sheet data as of Jun 30, 2026

Fundamentals & Valuation

No valuation has been published for this company yet.

Company Research

Research coverage for this company is in progress.

Narrative & Theme

This company is not currently mapped to a published narrative.

Business & Markets

No company profile has been published for this ticker yet.